A study of self-reported functional health, well-being, and disease burden among elderly subjects with (n=83) and without (n=93) wet AMD in Germany was conducted. Patients participated in structured telephone surveys, and reported their history of falls, fractures, and healthcare resource utilization. Furthermore, the healthcare utilization and unit costs for wet AMD patients were calculated.
Wet AMD is associated with decreased functional abilities and quality of life, which result in an increase in healthcare resource utilization. Consequently, costs were higher for wet AMD patients compared to controls. These findings emphasize the need for new AMD treatments that will prevent vision loss and progression to blindness, and lessen the ensuing economic burden.